Publication | Open Access
Alteration in TET1 as potential biomarker for immune checkpoint blockade in multiple cancers
118
Citations
32
References
2019
Year
TET1-MUT was strongly associated with higher ORR, better DCB, longer PFS, and improved OS in patients receiving ICI treatment, suggesting that TET1-MUT is a novel predictive biomarker for immune checkpoint blockade across multiple cancer types.
| Year | Citations | |
|---|---|---|
Page 1
Page 1